Alkermes’ fumarate prodrug patent upheld by EPO despite legalchallenges
MLex Summary: The Boards of Appeal of the European Patent Office upheld Alkermes' patent on fumarate prodrugs for treating neurological diseases, including multiple sclerosis, after challenges by Teva, Hexal and Generics....To view the full article, register now.
Already a subscriber? Click here to view full article